Evercore ISI raised the firm’s price target on Intuitive Surgical (ISRG) to $530 from $490 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical initiated with a Market Perform at CICC
- Morgan Stanley Sees Potential Growth in These 2 Surgical Robotic Stocks
- Intuitive Surgical price target raised to $640 from $570 at Truist
- Intuitive Surgical price target raised to $640 from $567 at Citi
- Intuitive announces publication of 30-day surgical outcomes involving da Vinci